Introduction
Methods
Protocol and registration
Eligibility criteria
Inclusion criteria | Exclusion criteria |
---|---|
Adult patients (≥ 18 years of age) Primary research English language Published 2001–2020 Patients undergoing cardiac surgical procedures | Surgical ablation procedures in isolation Ventricular Assist Device (VAD) procedures Studies that did not include multivariable analysis of predictors of HRQoL only Congenital heart disease Heart transplantation Transcatheter aortic valve implantation Descriptive exploration of interventions such as cardiac rehabilitation Studies that did not use a validated quality of life instrument Comparison of quality of life in patients who underwent cardiac surgery with those who received percutaneous coronary intervention |
Information sources, search strategy and study selection
Data collection and syntheses (data items and data collection process)
Risk of bias and quality assessment
Analysis
Results
Study selection
Study characteristics
Study (Author, year, country) | Study design (including (number of sites)) | Patients (population (type of surgery) and sample size) | HRQoL tool used and time-point of predictive model (months unless otherwise stated) | ||
---|---|---|---|---|---|
Type of surgery | Sample size | ||||
Participation rate of eligible persons | Completed follow-up: total cohort | ||||
Myles 2001 [12] Australia | Pre-op post-op (1) | CABG, valve, combined, other | 120/125 (96%) | 108/120 (90%) | SF-36 (3) |
Baldassarre 2002 [15] Canada | Prospective cohort (1) | Isolated CABG (primary) | 34/64 (53%) | 30/34 (88%) | SF-36 (3) |
Falcoz 2003 [34] France | Prospective cohort (1) | CABG, valve, combined, other (elective) | 293/452 (65%) | 264/293 (90%) | SF-36 (12) |
Herlitz 2003 [57] Sweden | Prospective cohort (2) | Isolated CABG (primary) | 1225/2000 (61%) | 976/2000 (49%) | NHP (10 years) |
Schelling 2003 [58] Germany | Prospective cohort (1) | CABG, valve, combined | 223/387 (58%) | 148/223 (66%) | SF-36 (6) |
Baberg 2004 [17] Germany | Prospective and retrospective cohort (1) | AVR ± MVR | 201/414 (47%) | 201/414 (49%) | SF-36 (3 years)a |
Jarvinen 2004 [28] Finland | Prospective cohort (1) | Isolated CABG | 501/1128 (44%) | 458/501 (91%) | SF-36 (12) |
Rumsfeld 2004 [18] America | Prospective cohort (14) | Isolated CABG (primary) | 2480/3956 (63%) | 1973/2480 (80%) | SF-36 (6) |
Al-Ruzzeh 2005 [19] UK | Cross-sectional (1) | Isolated CABG (primary) | 437/463 (94%) | NA | SF-36 (12)a |
Herlitz 2005 [59] Sweden | Prospective cohort (1) | Isolated CABG (primary) | 1225/2000 (61%) | 637/1225 (52%) | NHP (10 years)b |
Peric 2005 [60] Serbia and Montenegro | Prospective cohort (1) | Elective CABG | 243 (no mention of consent/refusal rate) | 226/243 (93%) | NHP (6) |
Le Grande 2006 [20] Australia | Pre-op post-op (1) | Elective CABG | 182/407 (45%) | 117/182 (64%) | SF-36 (2, 6) |
Myles 2006 [4] Australia | Pre-op post-op (1) | CABG, valve, combined, other | 108/120 (90%) | 93/108 (86%) | SF-36 (3, 3 years) |
Noyez 2006 [61] Netherlands | Retrospective cohort (1) | Isolated CABG | 428/428 (100%) | 428/428 (100%) | EQ-5D (12) |
Panagopoulou2006 [62] Greece | Prospective cohort (1) | Elective CABG | 157/256 (61%) | 1mo:117/157 (75%) 6mo:104/157 (66%) | MNHD-Q (1, 6) |
Dunning 2008 [63] England | Prospective cohort (1) | Isolated CABG | 911/1180 (77%) | 621/911 (68%) | EQ-5D (10)a |
El Baz 2008 [32] Netherlands | Prospective observational (2) | CABG | 198/256 (73%) | 168/198 (85%) | SF-36 (6) |
Jokinen 2008 [48] Finland | Prospective observational cohort (1) | CABG, valve, combined, other | 91/98 (93%) | 46/91 (51%) | NHP (15, 8.2 years)b |
Peric 2008 [64] Serbia | Pre-op post-op (1) | Isolated CABG | Not reported | 192/208 (92%) | NHP (6) |
Deaton 2009 [31] USA | Prospective cohort (2) | Isolated CABG | 317/442 (72%) | 270/317 (85%) | SF-36 (3)a |
Herlitz 2009 [65] Sweden | Prospective cohort (2) | Isolated CABG (primary) | Not reported 2000 screened | 639/2000 (32%) | NHP (15 years) |
Maisano 2009 [66] Italy (implied by authorship, not stated) | Retrospective cohort with prospective assessment of HRQoL (1) (implied) | Mitral valve surgery (± AVR, ± TV surgery, ± CABG) | 225/225 (100%) | 220/225 (98%) | MLHF (3 years)a |
Rantanen 2009 [67] Finland | Prospective cohort (1) | Elective CABG | 1 mo:274/367 (75%) 6 mo:244/271 (90%) 12 mo:236/266 (89%) | 1 mo:270/274 (99%) 6 mo:240/244 (98%) 12 mo:235/236 (100%) | 15D (1, 6, 12) |
Juergens 2010 [30] Germany | Prospective cohort (1) | Elective CABG, valve, combined | 56/85 (65%) | 42/65 (75%) | SF-12 (3) |
Peric 2010 [68] Serbia | Prospective pre-op post-op (1) | Elective CABG | 243/243 (100%) | 226/243 (93%) | NHP (6) |
Grady 2011 [21] America | Prospective cohort (1) | CABG, valve, maze, combined | 840/2524 (33%) | 0 mo:173/840 (21%) 6 mo:177/840 (21%) 12 mo:174/840 (21%) 24 mo:129/840 (15%) 36 mo:69/840 (8%) Total:816/840 (97%) | SF-36 (3, 6, 12, 2 years, 3 years) |
Vainiola 2013 [47] Finland | Prospective cohort (1) | CABG, valve, combined, aortic, other | 785/980 (80%) | 571/785 (73%) | 15-D (6) |
Kurfirst 2014 [14] Czech republic | Prospective cohort (1) | CABG, valve, combined (elective) | 310 eligible | 260/310 (84%) | SF-36 (12) |
Humphreys 2016 [33] Australia | Prospective cohort (1) | Elective CABG | 180 agreed to participate. No further details | 173/180 (96%) | SF-36 (6) |
Patron 2016 [22] Italy | Pre-op post-op (1) | CABG, valve, combined (primary, elective) | 92/92 (100%) | 75/92 (82%) | SF-12 (12) |
Bjornnes 2017 [69] Norway | Secondary analysis of RCT (2) | CABG, valve, combined | 416/525 (79%) | 349/416 (84%) | 15D (2 weeks, 3,6,12) |
Norkiene 2018 [13] Lithuania | Prospective cohort (1) | CABG, valve, combined | 210/210 (100%) No further details | 105/210 (50%) | SF-36 (12) |
Bishawi 2018 [70] America | Secondary analysis of RCT (18) | Isolated CABG (urgent or elective) | 2203/3670 (60%) | 1770/2203 (80%) | SAQVR-36 (12) |
Grand 2018 [23] France | Prospective cohort (1) | CABG, valve, combined (elective) | 495/548 (90%) | 326/495 (66%) | SF-36 (6) |
Coelho 2019 [24] Portugal | Prospective cohort (1) (implied) | CABG, valve, combined (elective) | Not stated | 384/430 (89%) | SF-36 (12) |
Blokzijl 2019 [25] Netherlands | Retrospective cohort multicentre (3) | Elective CABG | 2606/8643 (30%) | 2606/8643 (30%) | SF-36 or SF12 (10–14) |
Joskowiak 2019 [26] Germany | Prospective cohort (1) | CABG, valve, combined, aortic, other, redo (elective) | 164 consented but does not state number who were eligible and screened | 164/164 (100%) | SF-36 (12) |
Perrotti 2019 [27] France | Prospective cohort (1) | Isolated CABG (elective) | 272/272 (100%) | 118/272 (43%) | SF-36 (10 years) |
Kube 2020 [35] Germany | Prospective cohort (2) | CABG, valve, combined (elective) | 70/110 (64%) | 53/70 (76%) | SF-12 (6) |
Rijnhart-de Jong 2020 [29] | Prospective cohort (1) | Non-salvage cardiac surgery | 1544/1773 (87%) | 874/1544 (57%) | SF-36 (12) |
Schaal 2020 [71] Germany | Prospective cohort (1) | CABG, valve, combined, aortic, | 8676/14043 (62%) | 8676/14043 (62%) | NHP (6) |
Risk of bias
Independent predictors of HRQoL
Independent predictors of HRQoL between 1 and 6 months follow-up | Independent predictors of HRQoL between 1 year and 3.5 years follow-up | Independent predictors of HRQoL at 8.2 years and beyond | |
---|---|---|---|
Pre-operative variables | Alcohol use [33] BMI [31] Charlton Comorbidity Index [31] Chronic Heart Failure [33] Chronic neurological disease [18] COPD [18] Delirium [33] Depression [33] Ethnicity (aboriginal) [33] Everyday functioning questionnaire [20] FEV1 [18] Gender:Female [31] Geriatric depression scale [31] Health behaviours [33] History of renal insufficiency [32] Illness perception questionnaire [30] Peripheral vascular disease [18] Previous cardiac surgery [20] Pre-op 15-D [47] Pre-op expectations (IPQ-E) [35] Pre-op MacNew score [62] Pre-op MCS [18] Pre-op PCS [18] Pre-op SF-12 physical QoL [35] Pre-op SF-12 psychological Qo [35] Profile of mood state vigor-activity [20] Profile of mood state fatigue-inertia [20] Psychiatric disease [18] Psychological distress [62] QoR-40 [12] Serum creatinine [18] Stress symptom score [16] Work manual occupation [20] | Atrial fibrillation [66] Angina class [34] Back/neck problems [69] BMI [21] Cerebrovascular accident [70] Ethnicity (non-white) [21] Gastrointestinal tract problems [19] Gender [24] Gender/marital status interaction [69] Hypertension [21] Infection [29] MI [21] Mobility [61] Neurological disease [26] Other diseases [67] Pain intensity [69] Parsonnet score [34] PCI < 1 year [29] Peripheral or cerebral vascular Disease [34] Pre-op SAQ [70] Pre-op SF-36 [4] Pre-op VAS [61] Pre-op VR36 [70] Presence coronary artery disease [21] Pulmonary disease [25] QoR-40 [4] Redo surgery [21] Renal disease [25] Segment wall motion (abnormal) [34] Serum creatinine [66] Type D personality [19] Type valvular heart disease [17] | Angina [27] COPD [59] COPD/asthma [63] CCSC [63] Duration of cardiac symptoms pre-op > 120 days [48] Dyspnea [27] Height [59] Pre-op Nottingham Health Profile [57] Pre-op inferior QoL [65] Protective use of statin [48] Peripheral Vascular Disease [63] Redo surgery [63] Smoking [63] |
Intra-operative variables | Cardiopulmonary bypass duration [23] Higher mean pulmonary pressure [20] CABG procedure [71] | On cardiopulmonary bypass [34] Prosthetic valve type [17] CABG procedure [26] | Inotropic drugs at time of surgery [65] |
Post-operative variables | Aid from network members [67] Dobutamine [23] Length of hospital stay [32] MI [67] Prolonged LOS [31] New cardiac arrhythmia [20] No of categories of traumatic memory [16] Other diseases [67] Pain:severe and unbearable [47] Physical exertion causing symptoms [67] Post-op expectations (IPQ-E) [35] Post-op SF-12 physical QoL [35] Post-op SF-12 psychological QoL [35] Readmission to hospital within 6 weeks [32] Reexploration [32] Renal replacement for acute renal failure [23] Restlessness during ICU treatment [47] Sternal resuturing [32] Symptoms on mild exertion or at rest [67] Ventilation > 48 h [23] | Infective complications [19] Ejection fraction at follow-up [66] ICU LOS [24] Mitral regurgitation at follow-up echo [66] Perioperative MI [28] QoL at 1 month (15D) [67] Quality of life at 3 months [4] Poor QOR-40 at 1 month [4] Physical exertion causing symptoms [67] Post-operative rhythm [17] Sternal complications [17] Symptoms on mild exertion or at rest [67] Systolic pulmonary artery pressure at follow-up [66] | High pain score at 15 months [48] ICU time [65] ICU 2 days [63] ICU > 3 days [48] Length ventilator time [59] Low energy score at 15 months [48] |
Potentially modifiable predictors
Discussion
Strengths and limitations
Implications for practice
-
Cardiac surgery and enhanced recovery guidelines highlight the importance of HRQoL
-
Pre-operative lifestyle and therapeutic interventions relating to weight, alcohol use, psychological preparation and smoking cessation may improve HRQoL
-
Reducing chronic post-operative pain, in-hospital complications and length of hospital stay could also improve HRQoL.
-
More person-centred care, including HRQoL and shared decision-making, is needed to improve patient short- and longer-term recovery.